{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:49Z","timestamp":1791446809080,"version":"4.3.3"},"reference-count":151,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31902282"],"award-info":[{"award-number":["31902282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFE0119400"],"award-info":[{"award-number":["2019YFE0119400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.hlc.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:45:48Z","timestamp":1648489548000},"page":"934-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Immune Cells in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"31","author":[{"given":"Silu","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2022.02.007_bib1","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01214-2017","article-title":"The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension","volume":"51","author":"Marsh","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41598-020-58083-7","article-title":"Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia","volume":"10","author":"Bhagwani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2022.02.007_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1753465816665289","article-title":"A\u00a0review of therapeutic agents for the management of pulmonary arterial hypertension","volume":"11","author":"Hahn","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.hlc.2022.02.007_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/jim-2020-001291","article-title":"Clinical update on pulmonary hypertension","volume":"68","author":"Yaghi","year":"2020","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41440-020-0457-6","article-title":"A\u00a0novel rat model of pulmonary hypertension induced by mono treatment with SU5416","volume":"43","author":"Chen","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ajpath.2019.02.005","article-title":"Plexiform arteriopathy in rodent models of pulmonary arterial hypertension","volume":"189","author":"Carman","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hlc.2022.02.007_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020922129","article-title":"Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension","volume":"10","author":"Zhu","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2022.02.007_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chest.2016.01.004","article-title":"Regulatory t cell dysfunction in idiopathic, heritable and connective tissue-associated pulmonary arterial hypertension","volume":"149","author":"Huertas","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib10","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41401-019-0272-2","article-title":"Crosstalk between the Akt\/mTORC1 and Nf-kappa B signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCS","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.hlc.2022.02.007_bib11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.624714","article-title":"Identification of potential biomarkers and immune infiltration characteristics in idiopathic pulmonary arterial hypertension using bioinformatics analysis","volume":"8","author":"Zeng","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/abbs\/gmx095","article-title":"Immune cells and autoantibodies in pulmonary arterial hypertension","volume":"49","author":"Li","year":"2017","journal-title":"Acta Bioch Bioph Sin"},{"key":"10.1016\/j.hlc.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-3-030-63046-1_19","article-title":"Inflammation in pulmonary arterial hypertension","volume":"1303","author":"Klouda","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hlc.2022.02.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111081","article-title":"Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"133","author":"Tang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.hlc.2022.02.007_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-030-63046-1_15","article-title":"Cytokines, chemokines, and inflammation in pulmonary arterial hypertension","volume":"1303","author":"Liang","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hlc.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-030-63046-1_2","article-title":"Galectin-3 promotes ROS, inflammation, and vascular fibrosis in pulmonary arterial hypertension","volume":"1303","author":"Barman","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hlc.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/2045-8932.97609","article-title":"Mast cell number, phenotype, and function in human pulmonary arterial hypertension","volume":"2","author":"Farha","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2022.02.007_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112338","article-title":"Perivascular inflammation in pulmonary arterial hypertension","volume":"9","author":"Hu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.hlc.2022.02.007_bib20","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib21","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14532","article-title":"Adaptive and innate immune mechanisms in cardiac fibrosis complicating pulmonary arterial hypertension","volume":"8","author":"Siamwala","year":"2020","journal-title":"Physiol Rep"},{"key":"10.1016\/j.hlc.2022.02.007_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13594","article-title":"Keratin 1: A negative regulator of inflammation and potential treatment for pulmonary arterial hypertension","volume":"231","author":"Trittmann","year":"2021","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.hlc.2022.02.007_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114130","article-title":"MnTBAP reverses pulmonary vascular remodeling and improves cardiac function in experimentally induced pulmonary arterial hypertension","volume":"21","author":"Gomez-Puerto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hlc.2022.02.007_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1536\/ihj.19-096","article-title":"Alginate oligosaccharide alleviates monocrotaline-induced pulmonary hypertension via anti-oxidant and anti-inflammation pathways in rats","volume":"61","author":"Feng","year":"2020","journal-title":"Int Heart J"},{"key":"10.1016\/j.hlc.2022.02.007_bib25","doi-asserted-by":"crossref","first-page":"108749","DOI":"10.1016\/j.cbi.2019.108749","article-title":"Protective effects of 18beta-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A\/Rho kinsase pathway","volume":"311","author":"Zhang","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.hlc.2022.02.007_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00094706","article-title":"Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2022.02.007_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived cc chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib30","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.14-1678","article-title":"T-helper 17 cell polarization in pulmonary arterial hypertension","volume":"147","author":"Hautefort","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1582-4934.2008.00370.x","article-title":"Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating e47\/c-myb binding (Retracted Article)","volume":"14","author":"Shen","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib32","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"42","author":"Savai","year":"2013","journal-title":"Eur Resp J"},{"key":"10.1016\/j.hlc.2022.02.007_bib33","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20171767","article-title":"Inhibition of CRTH2-mediated th2 activation attenuates pulmonary hypertension in mice","volume":"215","author":"Chen","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12890-016-0301-6","article-title":"Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension","volume":"16","author":"Harbaum","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2014.06.1014","article-title":"Effect of TH17 and Treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases","volume":"64","author":"Gaowa","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T cells in systemic sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib37","doi-asserted-by":"crossref","first-page":"680109","DOI":"10.3389\/fcvm.2021.680109","article-title":"Autoimmunity in pulmonary arterial hypertension: evidence for local immunoglobulin production","volume":"8","author":"Shu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/eji.201747460","article-title":"Circulating\u00a0plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension","volume":"48","author":"Blum","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/thoraxjnl-2020-215460","article-title":"Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension","volume":"76","author":"Heukels","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.hlc.2022.02.007_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.hlc.2022.02.007_bib41","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1183\/09031936.00140109","article-title":"Small airway obstruction in severe pulmonary arterial hypertension correlates with increased airway CD8+ T-cells and fractalkine expression","volume":"34","author":"Ars","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2022.02.007_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41419-018-0315-5","article-title":"Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension","volume":"9","author":"Mao","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hlc.2022.02.007_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.1041600310","article-title":"Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: dependence on cell size, time from birth, insulin-like growth factor i, and auto-activation of protein kinase C","volume":"160","author":"Dempsey","year":"1994","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1465-9921-12-99","article-title":"Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations","volume":"12","author":"Pfarr","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1465-9921-14-3","article-title":"Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension","volume":"14","author":"Pfarr","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.152.1.7599869","article-title":"Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary-hypertension","volume":"152","author":"Loyd","year":"1995","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.hlc.2022.02.007_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","article-title":"Bone morphogenetic protein receptor type ii deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension","volume":"192","author":"Soon","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2010-05-285973","article-title":"Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function","volume":"117","author":"Burton","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.hlc.2022.02.007_bib49","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1136\/thoraxjnl-2012-202678.004","article-title":"Mutations in bmpr-ii promote inflammation via altered superoxide signalling: insights into the mechanisms underlying pulmonary arterial hypertension","volume":"67","author":"Soon","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.hlc.2022.02.007_bib50","first-page":"167","article-title":"The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities","volume":"85","author":"Padmanabhan","year":"2012","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib51","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.hlc.2022.02.007_bib52","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.chest.2021.06.028","article-title":"Severe pulmonary arterial hypertension is characterized by increased neutrophil elastase and relative elafin deficiency","volume":"160","author":"Sweatt","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmed.2018.00217","article-title":"The role of neutrophils and neutrophil elastase in pulmonary arterial hypertension","volume":"5","author":"Taylor","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib54","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscl Throm Vas"},{"key":"10.1016\/j.hlc.2022.02.007_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cmdc.201500269","article-title":"Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine bay-8040 in a pulmonary arterial hypertension rat model","volume":"11","author":"von Nussbaum","year":"2016","journal-title":"Chemmedchem"},{"key":"10.1016\/j.hlc.2022.02.007_bib56","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00424-016-1899-1","article-title":"Bmprii influences the response of pulmonary microvascular endothelial cells to inflammatory mediators","volume":"468","author":"Vengethasamy","year":"2016","journal-title":"Pflug Arch Eur J Phy"},{"key":"10.1016\/j.hlc.2022.02.007_bib57","article-title":"Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice (vol 294, pg h677, 2008)","volume":"297","author":"Song","year":"2009","journal-title":"Am J Physiol-Heart C"},{"key":"10.1016\/j.hlc.2022.02.007_bib58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2012.08.106","article-title":"Viral toll like receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension","volume":"426","author":"George","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hlc.2022.02.007_bib59","article-title":"First identification of Kruppel-like factor 2 mutation in heritable pulmonary arterial hypertension","volume":"197","author":"Eichstaedt","year":"2018","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.hlc.2022.02.007_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1101530","article-title":"Kruppel-like factors in lymphocyte biology","volume":"188","author":"Hart","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib61","article-title":"Kruppel-like factor 2 (KLF2) in immune cell migration","volume":"9","author":"Wittner","year":"2021","journal-title":"Vaccines-Basel"},{"key":"10.1016\/j.hlc.2022.02.007_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10741-017-9612-9","article-title":"Drug-induced pulmonary arterial hypertension: A review","volume":"22","author":"Garg","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hlc.2022.02.007_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1742-1241.2010.02606.x","article-title":"Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead","volume":"65","author":"Perez","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.hlc.2022.02.007_bib64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/vim.2017.0051","article-title":"Lung vascular remodeling, cardiac hypertrophy, and inflammatory cytokines in SHIVnef-infected macaques","volume":"31","author":"Almodovar","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib65","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/j.2040-4603.2011.tb00376.x","article-title":"Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension","volume":"1","author":"El Chami","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib66","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.97.5.1032","article-title":"Pulmonary disease associated with l-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features","volume":"97","author":"Tazelaar","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib67","article-title":"The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)","volume":"8","author":"MacLean","year":"2018","journal-title":"Pulmon Circ"},{"key":"10.1016\/j.hlc.2022.02.007_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/00001573-199909000-00013","article-title":"Pulmonary hypertension related to drugs and toxins (vol 14, pg 437, 1999)","volume":"14","author":"Abenhaim","year":"1999","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","article-title":"5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension","volume":"131","author":"MacLean","year":"2000","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.hlc.2022.02.007_bib70","doi-asserted-by":"crossref","first-page":"L795","DOI":"10.1152\/ajplung.1997.272.5.L795","article-title":"A new role for an old molecule: Serotonin as a mitogen","volume":"272","author":"Fanburg","year":"1997","journal-title":"Am J Physiol-Lung C"},{"key":"10.1016\/j.hlc.2022.02.007_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2007.01497.x","article-title":"Pulmonary hypertension and the serotonin hypothesis: where are we now?","volume":"61","author":"MacLean","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.hlc.2022.02.007_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00186","article-title":"Serotonin: a potent immune cell modulator in autoimmune diseases","volume":"11","author":"Wan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib73","first-page":"837","article-title":"Aminorex and pulmonary circulation","volume":"25","author":"Seiler","year":"1975","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.hlc.2022.02.007_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/rr181","article-title":"Anorexigen-induced pulmonary hypertension and the serotonin (5-ht) hypothesis: lessons for the future in pathogenesis","volume":"3","author":"Eddahibi","year":"2002","journal-title":"Respir Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.hlc.2022.02.007_bib76","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/CIRCULATIONAHA.108.767558","article-title":"Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice","volume":"117","author":"Dempsie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.02.007_bib77","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1096\/fj.06-8058com","article-title":"The 5-HT transporter transactivates the PDGF beta receptor in pulmonary artery smooth muscle cells","volume":"21","author":"Liu","year":"2007","journal-title":"Faseb J"},{"key":"10.1016\/j.hlc.2022.02.007_bib78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.carpath.2013.03.003","article-title":"Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1\/2 and PDK through 5-HT1B receptors and 5-ht transporters","volume":"22","author":"Liu","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hlc.2022.02.007_bib79","doi-asserted-by":"crossref","DOI":"10.1378\/chest.128.6_suppl.552S","article-title":"Serotonin transporter and receptors in various forms of human pulmonary hypertension","volume":"128","author":"Marcos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib80","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0008-8749(84)90096-0","article-title":"Mechanisms of serotonin-induced lymphocyte proliferation inhibition","volume":"84","author":"Slauson","year":"1984","journal-title":"Cell Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib81","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2005-07-2903","article-title":"A\u00a0novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and t cells","volume":"107","author":"O'Connell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hlc.2022.02.007_bib82","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1471-4906(03)00176-5","article-title":"Lymphocytes transport serotonin and dopamine: agony or ecstasy?","volume":"24","author":"Gordon","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib83","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.4049\/jimmunol.158.6.2891","article-title":"Human platelets can initiate t cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies","volume":"158","author":"Matsuda","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02166.x","article-title":"Close encounters of the monoamine kind: Immune cells betray their nervous disposition","volume":"115","author":"Meredith","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.hlc.2022.02.007_bib85","doi-asserted-by":"crossref","first-page":"L272","DOI":"10.1152\/ajplung.00032.2010","article-title":"Serotonin activates murine alveolar macrophages through 5-HT2C receptors","volume":"299","author":"Mikulski","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib86","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1021\/acschemneuro.6b00414","article-title":"Diverse effects of gut-derived serotonin in intestinal inflammation","volume":"8","author":"Shajib","year":"2017","journal-title":"Acs Chem Neurosci"},{"key":"10.1016\/j.hlc.2022.02.007_bib87","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","article-title":"Serotonin provides an accessory signal to enhance t-cell activation by signaling through the 5-HT7 receptor","volume":"109","author":"Leon-Ponte","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hlc.2022.02.007_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","article-title":"Inflammation in pulmonary arterial hypertension","volume":"141","author":"Price","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2010-0097OC","article-title":"Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction","volume":"45","author":"Dhillon","year":"2011","journal-title":"Am J Resp Cell Mol"},{"key":"10.1016\/j.hlc.2022.02.007_bib90","article-title":"Macrophage--derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse (vol 32, pg 5174, 2018)","volume":"35","author":"Sharma","year":"2021","journal-title":"Faseb J"},{"key":"10.1016\/j.hlc.2022.02.007_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/10739680600930305","article-title":"Ca2+ channels and chronic hypoxia","volume":"13","author":"Shimoda","year":"2006","journal-title":"Microcirculation"},{"key":"10.1016\/j.hlc.2022.02.007_bib92","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.RES.0000227551.68124.98","article-title":"Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular ca2+ in pulmonary arterial smooth muscle cells","volume":"98","author":"Wang","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib93","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pneumo.2011.06.006","article-title":"[pulmonary arterial hypertension related to HIV: Is inflammation related to il-6 the cornerstone?]","volume":"67","author":"Tcherakian","year":"2011","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.hlc.2022.02.007_bib94","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0b013e32835099ae","article-title":"Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era","volume":"26","author":"Morris","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.hlc.2022.02.007_bib95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.4319","article-title":"Hiv persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy","volume":"23","author":"Honeycutt","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/aid.2018.0132","article-title":"Monocyte and alveolar macrophage skewing is associated with the development of pulmonary arterial hypertension in a primate model of HIV infection","volume":"35","author":"Schweitzer","year":"2019","journal-title":"Aids Res Hum Retrov"},{"key":"10.1016\/j.hlc.2022.02.007_bib97","article-title":"Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH","volume":"9","author":"Rabacal","year":"2019","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.hlc.2022.02.007_bib98","first-page":"338","article-title":"Arteriopathy in macaques infected with simian immunodeficiency virus","volume":"67","author":"Chalifoux","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.hlc.2022.02.007_bib99","first-page":"213","article-title":"Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model","volume":"70","author":"Fan","year":"2021","journal-title":"Physiol Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dvg.22343","article-title":"Generation of a novel mouse model for the inducible depletion of macrophages in\u00a0vivo","volume":"51","author":"Gheryani","year":"2013","journal-title":"Genesis"},{"key":"10.1016\/j.hlc.2022.02.007_bib102","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/ATVBAHA.120.314639","article-title":"Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension","volume":"41","author":"Zawia","year":"2021","journal-title":"Arterioscl Throm Vas"},{"key":"10.1016\/j.hlc.2022.02.007_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006674","article-title":"Blocking macrophage leukotriene b-4 prevents endothelial injury and reverses pulmonary hypertension","volume":"5","author":"Tian","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib104","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.05.00112105","article-title":"Pulmonary arterial hypertension: an autoimmune disease?","volume":"26","author":"Mouthon","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2022.02.007_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2019.00011","article-title":"Dendritic cell subsets and effector function in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"10","author":"van Uden","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib106","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1165\/rcmb.2012-0182OC","article-title":"Ccr2 deficiency, dysregulation of notch signaling, and spontaneous pulmonary arterial hypertension","volume":"48","author":"Yu","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hlc.2022.02.007_bib107","doi-asserted-by":"crossref","first-page":"247372","DOI":"10.1155\/2014\/247372","article-title":"Effect of th17 and treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases","volume":"2014","author":"Gaowa","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.hlc.2022.02.007_bib108","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/resp.12152","article-title":"Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension","volume":"18","author":"Edwards","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.hlc.2022.02.007_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2010.03285.x","article-title":"Inflammation, immunological reaction and role of infection in pulmonary hypertension","volume":"17","author":"Pullamsetti","year":"2011","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.hlc.2022.02.007_bib110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12016-011-8265-z","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","volume":"44","author":"Kherbeck","year":"2013","journal-title":"Clin Rev Allerg Immu"},{"key":"10.1016\/j.hlc.2022.02.007_bib111","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1016\/j.lpm.2014.06.007","article-title":"Update in systemic sclerosis-associated pulmonary arterial hypertension","volume":"43","author":"Gashouta","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib112","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.hlc.2022.02.007_bib113","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/2045-8932.93544","article-title":"Significant intrapulmonary schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension","volume":"1","author":"Graham","year":"2011","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2022.02.007_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2010.03308.x","article-title":"Pulmonary vascular disease associated with parasitic infection--the role of schistosomiasis","volume":"17","author":"Kolosionek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.hlc.2022.02.007_bib115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1471-2334-14-282","article-title":"Tgf beta and il13 in schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups","volume":"14","author":"Ferreira Rde","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.hlc.2022.02.007_bib116","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-3024.2009.01098.x","article-title":"Immunopathogenesis of human schistosomiasis","volume":"31","author":"Burke","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.hlc.2022.02.007_bib118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The m1 and m2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.hlc.2022.02.007_bib119","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hlc.2022.02.007_bib120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.hlc.2022.02.007_bib121","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib122","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.carpath.2004.06.003","article-title":"Decreased numbers of t-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts","volume":"13","author":"Pinto","year":"2004","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hlc.2022.02.007_bib123","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12893-020-01009-x","article-title":"Predictive role of perioperative neutrophil to lymphocyte ratio in pediatric congenital heart disease associated with pulmonary arterial hypertension","volume":"21","author":"Yin","year":"2021","journal-title":"BMC Surg"},{"key":"10.1016\/j.hlc.2022.02.007_bib124","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1532\/hsf.1228","article-title":"Inflammation and congenital heart disease associated pulmonary hypertension","volume":"18","author":"Gursoy","year":"2015","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.hlc.2022.02.007_bib125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1164\/ajrccm.160.4.9810058","article-title":"Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease","volume":"160","author":"Hamada","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib126","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.21037\/jtd.2018.05.59","article-title":"New dynamic viewing of mast cells in pulmonary arterial hypertension (pah): Contributors or outsiders to cardiovascular remodeling","volume":"10","author":"Xu","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.hlc.2022.02.007_bib127","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/675642","article-title":"Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease","volume":"4","author":"Kosanovic","year":"2014","journal-title":"Pulm Circ"},{"issue":"Suppl 11","key":"10.1016\/j.hlc.2022.02.007_bib128","first-page":"S62","article-title":"Angiotensin ii signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases","volume":"10","author":"Berk","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.hlc.2022.02.007_bib129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1378\/chest.11-0663","article-title":"Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension","volume":"141","author":"Bartelds","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib130","doi-asserted-by":"crossref","first-page":"7305028","DOI":"10.1155\/2019\/7305028","article-title":"Relation of macrophage migration inhibitory factor to pulmonary hemodynamics and vascular structure and carbamyl-phosphate synthetase i genetic variations in pediatric patients with congenital cardiac shunts","volume":"2019","author":"Maeda","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.hlc.2022.02.007_bib131","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib132","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/rccm.202009-3481OC","article-title":"Safety and efficacy of b-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"204","author":"Zamanian","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib133","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BOR.0000000000000835","article-title":"Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: Recent insights and therapeutic implications","volume":"33","author":"Lescoat","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.hlc.2022.02.007_bib134","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2012-0429OC","article-title":"Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension","volume":"48","author":"Houssaini","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hlc.2022.02.007_bib135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/ajrccm.163.2.2006093","article-title":"40-o-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats","volume":"163","author":"Nishimura","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib136","doi-asserted-by":"crossref","first-page":"L933","DOI":"10.1152\/ajplung.00310.2006","article-title":"Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study","volume":"293","author":"McMurtry","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2022.02.007_bib137","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/674311","article-title":"Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial","volume":"3","author":"Seyfarth","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2022.02.007_bib138","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2004.03.018","article-title":"Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease","volume":"175","author":"Hillyard","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2022.02.007_bib139","first-page":"1446","article-title":"Simvastatin treatment of pulmonary hypertension: an observational case series","volume":"127","author":"Kao","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.02.007_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.932221","article-title":"Lung mast cells and hypoxic pulmonary hypertension","volume":"61","author":"Maxova","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib141","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1183\/09031936.00043310","article-title":"Mast cells promote lung vascular remodelling in pulmonary hypertension","volume":"37","author":"Hoffmann","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2022.02.007_bib142","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yexcr.2017.06.017","article-title":"An upregulation of CD8(+)CD25(+)Foxp3(+) T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension","volume":"358","author":"Zhu","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib143","first-page":"275","article-title":"Exuberant endothelial-cell growth and elements of inflammation are present in plexiform lesions of pulmonary-hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hlc.2022.02.007_bib144","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1161\/CIRCRESAHA.117.312058","article-title":"Dominant role for regulatory T cells in protecting females against pulmonary hypertension","volume":"122","author":"Tamosiuniene","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2022.02.007_bib145","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1164\/rccm.2009111-699OC","article-title":"Simvastatin as a treatment for pulmonary hypertension trial","volume":"181","author":"Wilkins","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib146","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/76282","article-title":"Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor","volume":"6","author":"Cowan","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib147","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ajpath.2011.05.051","article-title":"Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions","volume":"179","author":"Kim","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hlc.2022.02.007_bib148","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201412-2291OC","article-title":"Elafin reverses pulmonary hypertension via caveolin-1-dependent bone morphogenetic protein signaling","volume":"191","author":"Nickel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib149","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.201504-0686ED","article-title":"Elafin in pulmonary arterial hypertension. Beyond targeting elastases","volume":"191","author":"Chun","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2022.02.007_bib150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/hc0402.102866","article-title":"Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension","volume":"105","author":"Zaidi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.02.007_bib151","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","article-title":"Regulatory t cells limit vascular endothelial injury and prevent pulmonary hypertension","volume":"109","author":"Tamosiuniene","year":"2011","journal-title":"Circ Res"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:05:52Z","timestamp":1761415552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":151,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1443950622000750"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2022.02.007","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Cells in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}